BLT 0.00% 2.6¢ benitec biopharma limited

Current management team is incompetent and unable to deliver the...

  1. 89 Posts.
    lightbulb Created with Sketch. 1
    Current management team is incompetent and unable to deliver the value the BLT science deserves.
    The sooner this is resolved the better otherwise we will all loose on the potential re-rate. 25% upswing from a rock bottom MC/SP is not much to be cheering about. The BLT management team collected plenty of rewards (rewarding themselves) to date for a rather pathetic result. Outside of science, this has been very badly managed. If they were working for you, you'd dismiss them long time ago. There is nothing to suggest there is anything of substance happening behind the scenes. Such claims are made across ASX with impunity.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.